Join our 20.000 subscribers and receive the monthly newsletter for free!

RELATED ARTICLES
Prof. Carmeliet as Chief Scientific Strategy Advisor at Oncurious

Oncurious NV, an oncology company focused on the development of innovative medicines for the treatment of pediatric tumors, today announces the ap…

POPULAR TAGS

ThromboGenics and VIB found oncology company

Written by DS on in the category news with the tags , .



Oncurious is a new oncology company that will perform clinical trials for the development of TB-403. This compound is a new promising agent for the treatment of brain tumors in children. Alongside ThromboGenics, VIB (Flemish Institute for Biotechnology) will be a shareholder.

Medulloblastoma is a rare, but life-threatening, brain tumor that  occurs mostly in children. In this type of cancer, PLGF (placental growth factor) is (over-)expressed. TB-403 is a monoclonal antibody directed against PLGF. Animal studies were promising and the safety profile is favorable. TB-403 also has  potential as a treatment for other pediatric tumours. Johan Cardoen, executive at VIB, hopes to make Oncurious into a leading oncology company. 

Read more about this topic in our soon to be published Insights article.

Read more about: , .

RELATED ARTICLES
Prof. Carmeliet as Chief Scientific Strategy Advisor at Oncurious

Oncurious NV, an oncology company focused on the development of innovative medicines for the treatment of pediatric tumors, today announces the ap…

POPULAR TAGS

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK Flanders.bio Turnstone UGent Janssen XpandInnovation Biowin KU Leuven Itera Life Science V-Bio Ventures

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.